Cancer Genetics, Inc. (Nasdaq: CGIX) (“CGI” or “The Company”), a leader precision diagnostics for oncology, announced a strategic collaboration with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE